RCM Diligence — Checklist
Orchestration layer · auto-tracked from live analytics
🛡️ Public data only — no PHI permitted on this instance.
Diligence Checklist
Coverage + Open Questions
Auto-tracked from live analytics · partner overrides via URL
7 P0 items still open + 10 P1 — P0 coverage 65%. Do not schedule IC until P0 = 100%.
How to read: P0 coverage is the single go/no-go gauge for IC. Items tied to analytics auto-mark DONE when the analytic is run. Manual items (management references, legal review) need an explicit override — "Mark done" link on each row. All overrides are URL-encoded so you can share a state snapshot by copying the URL.
P0 coverage
65%
Blocking IC
Total done
20/40
50% of all items
Open P0
7
must close before IC
Open P1
10
assign owners
Open questions for IC (17)
Every P0/P1 item that remains OPEN or BLOCKED. This list is what the IC Packet "Open Questions" section prints — close the loop on each before the memo ships.
P0Has the HCRIS-Native Peer X-Ray benchmarked the target against 25-50 filed Medicare cost reports?ANALYST
P0Seller legal review — corporate structure, equity rollover, reps + warranties — signed off?LEGAL
P0Commercial payer contract review — top-5 payer contracts' carveouts, escalators, termination clauses, auto-renewal?LEGAL
P0Has the Regulatory Calendar × Thesis Kill-Switch been run to map upcoming CMS / OIG / FTC / DOJ / NSA-IDR events to the target's thesis drivers?ANALYST
P0Has the Covenant & Capital Stack Stress Lab been run to quantify per-quarter covenant-breach probability and equity-cure sizing?ANALYST
P0Quality-of-Earnings memo drafted and reviewed?PARTNER
P0IC Packet assembled (12 sections with partner synthesis + walkaway + open questions)?PARTNER
P1Is the sector sentiment from the market-intel feed consistent with the deal thesis?ANALYST
P1Cost to collect benchmarked against HFMA peer median?ANALYST
P1Corporate Practice of Medicine (CPOM) state exposure assessed?LEGAL
P1TEAM (CMS Transforming Episode Accountability) exposure reviewed?ANALYST
P1Labor + referral leakage reviewed (synthetic FTE, wage inflation, referral concentration)?ANALYST
P1Management team reference calls (CEO / CFO / RCM-ops director) completed?PARTNER
P1Real estate title + environmental + survey report for every owned facility?EXTERNAL
P1Seller disclosure schedule review — pending litigation, regulatory audits, DOJ/OIG matters?LEGAL
P1Has the Payer Mix Stress Lab stress-tested the target's commercial + government payer portfolio?ANALYST
P1Normalised working-capital target estimated + reconciled to seller's proposed peg?ANALYST
Items by phase · click an evidence link to drill in
Phase 1 · Pre-NDA screening
2/4 done · 50%
DONEP0
Has the Bankruptcy-Survivor Scan been run against the 12 named failure patterns?
SCREENING
ANALYST
DONEP0
Has a historical-analog signature match been run (Deal Autopsy)?
SCREENING
ANALYST
BLOCKEDP1
Is the sector sentiment from the market-intel feed consistent with the deal thesis?
SCREENING
ANALYST
Phase 2 · CCD benchmarks + predictive
9/11 done · 82%
DONEP0
Has the Canonical Claims Dataset been ingested from the seller's 837/835 files?
INGEST
ANALYST
DONEP0
Days in A/R benchmarked against HFMA peer median?
BENCHMARKS
ANALYST
DONEP0
First-pass denial rate benchmarked against HFMA peer median?
BENCHMARKS
ANALYST
OPENP1
Cost to collect benchmarked against HFMA peer median?
BENCHMARKS
ANALYST
DONEP1
Cohort liquidation curve computed (shows cohort censoring + liquidation tail)?
BENCHMARKS
ANALYST
DONEP0
Quality-of-Revenue waterfall reconciliation run against management revenue?
BENCHMARKS
ANALYST
IN PROGRESSP0
Claim-level denial prediction model trained and calibrated?
PREDICTIVE
ANALYST
Phase 3 · Risk workbench + manual diligence
5/17 done · 29%
OPENP1
Corporate Practice of Medicine (CPOM) state exposure assessed?
RISK
LEGAL
DONEP0
No Surprises Act exposure assessed (OON share + IDR arbitration exposure)?
RISK
ANALYST
IN PROGRESSP0
Real-estate Steward Score computed (sale-leaseback risk + EBITDAR coverage)?
RISK
ANALYST
OPENP1
TEAM (CMS Transforming Episode Accountability) exposure reviewed?
RISK
ANALYST
DONEP0
Antitrust / HHI concentration check for the target's footprint?
RISK
LEGAL
DONEP0
Physician comp benchmarked against FMV p25/p50/p75 + Stark red-lines checked?
RISK
LEGAL
OPENP1
Labor + referral leakage reviewed (synthetic FTE, wage inflation, referral concentration)?
RISK
ANALYST
OPENP1
Management team reference calls (CEO / CFO / RCM-ops director) completed?
MANUAL
PARTNER
OPENP0
Seller legal review — corporate structure, equity rollover, reps + warranties — signed off?
MANUAL
LEGAL
OPENP0
Commercial payer contract review — top-5 payer contracts' carveouts, escalators, termination clauses, auto-renewal?
MANUAL
LEGAL
OPENP1
Real estate title + environmental + survey report for every owned facility?
MANUAL
EXTERNAL
OPENP1
Seller disclosure schedule review — pending litigation, regulatory audits, DOJ/OIG matters?
MANUAL
LEGAL
OPENP0
Has the Regulatory Calendar × Thesis Kill-Switch been run to map upcoming CMS / OIG / FTC / DOJ / NSA-IDR events to the target's thesis drivers?
RISK
ANALYST
Phase 4 · Financial synthesis
4/6 done · 67%
DONEP0
EBITDA bridge with 7 levers built (denial reduction, coding uplift, contract yield, WC optimization, labor inflation, reg-headwind, cyber reserve)?
FINANCIAL
ANALYST
DONEP0
Deal Monte Carlo run (3000 trials, 5-year forward MOIC/IRR distribution, variance attribution, sensitivity tornado)?
FINANCIAL
ANALYST
DONEP0
Counterfactual Advisor — offer-shape modifications to flip every RED/CRITICAL finding?
FINANCIAL
PARTNER
DONEP1
Public-operator comps + transaction multiples pulled for the target's category?
MARKET
ANALYST
OPENP1
Normalised working-capital target estimated + reconciled to seller's proposed peg?
FINANCIAL
ANALYST
Phase 5 · Partner deliverables
0/2 done · 0%
Flat view · sortable · filterable · CSV export
| Item | Phase | Category | Priority | Status | Owner | Question |
|---|---|---|---|---|---|---|
| scan_bankruptcy_survivor | 1 | SCREENING | P0 | DONE | ANALYST | Has the Bankruptcy-Survivor Scan been run against the 12 named failure patterns? |
| scan_deal_autopsy | 1 | SCREENING | P0 | DONE | ANALYST | Has a historical-analog signature match been run (Deal Autopsy)? |
| scan_sector_sentiment | 1 | SCREENING | P1 | BLOCKED | ANALYST | Is the sector sentiment from the market-intel feed consistent with the deal thesis? |
| ingest_ccd | 2 | INGEST | P0 | DONE | ANALYST | Has the Canonical Claims Dataset been ingested from the seller's 837/835 files? |
| benchmark_days_in_ar | 2 | BENCHMARKS | P0 | DONE | ANALYST | Days in A/R benchmarked against HFMA peer median? |
| benchmark_denial_rate | 2 | BENCHMARKS | P0 | DONE | ANALYST | First-pass denial rate benchmarked against HFMA peer median? |
| benchmark_ar_aging | 2 | BENCHMARKS | P0 | DONE | ANALYST | A/R aging > 90 days benchmarked? |
| benchmark_cost_to_collect | 2 | BENCHMARKS | P1 | OPEN | ANALYST | Cost to collect benchmarked against HFMA peer median? |
| benchmark_net_revenue_realization | 2 | BENCHMARKS | P0 | DONE | ANALYST | Net revenue realization benchmarked? |
| benchmark_cohort_liquidation | 2 | BENCHMARKS | P1 | DONE | ANALYST | Cohort liquidation curve computed (shows cohort censoring + liquidation tail)? |
| benchmark_denial_pareto | 2 | BENCHMARKS | P1 | DONE | ANALYST | Denial Pareto root-cause table produced? |
| benchmark_qor_waterfall | 2 | BENCHMARKS | P0 | DONE | ANALYST | Quality-of-Revenue waterfall reconciliation run against management revenue? |
| predictive_denial_model | 2 | PREDICTIVE | P0 | IN PROGRESS | ANALYST | Claim-level denial prediction model trained and calibrated? |
| predictive_physician_attrition | 2 | PREDICTIVE | P0 | DONE | ANALYST | Physician flight-risk (P-PAM) scored across the roster? |
| risk_cpom | 3 | RISK | P1 | OPEN | LEGAL | Corporate Practice of Medicine (CPOM) state exposure assessed? |
| risk_nsa | 3 | RISK | P0 | DONE | ANALYST | No Surprises Act exposure assessed (OON share + IDR arbitration exposure)? |
| risk_steward | 3 | RISK | P0 | IN PROGRESS | ANALYST | Real-estate Steward Score computed (sale-leaseback risk + EBITDAR coverage)? |
| risk_team | 3 | RISK | P1 | OPEN | ANALYST | TEAM (CMS Transforming Episode Accountability) exposure reviewed? |
| risk_antitrust | 3 | RISK | P0 | DONE | LEGAL | Antitrust / HHI concentration check for the target's footprint? |
| risk_cyber | 3 | RISK | P0 | DONE | ANALYST | Cyber posture composite + BI-loss estimate produced? |
| risk_ma_v28 | 3 | RISK | P0 | DONE | ANALYST | Medicare Advantage V28 recalibration impact computed? |
| risk_physician_comp_fmv | 3 | RISK | P0 | DONE | LEGAL | Physician comp benchmarked against FMV p25/p50/p75 + Stark red-lines checked? |
| risk_labor_referral | 3 | RISK | P1 | OPEN | ANALYST | Labor + referral leakage reviewed (synthetic FTE, wage inflation, referral concentration)? |
| risk_patient_pay | 3 | RISK | P2 | OPEN | ANALYST | Patient-pay + reputational overlays reviewed? |
| fin_ebitda_bridge | 4 | FINANCIAL | P0 | DONE | ANALYST | EBITDA bridge with 7 levers built (denial reduction, coding uplift, contract yield, WC optimization, labor inflation, reg-headwind, cyber reserve)? |
| fin_deal_mc | 4 | FINANCIAL | P0 | DONE | ANALYST | Deal Monte Carlo run (3000 trials, 5-year forward MOIC/IRR distribution, variance attribution, sensitivity tornado)? |
| fin_counterfactual | 4 | FINANCIAL | P0 | DONE | PARTNER | Counterfactual Advisor — offer-shape modifications to flip every RED/CRITICAL finding? |
| fin_market_intel | 4 | MARKET | P1 | DONE | ANALYST | Public-operator comps + transaction multiples pulled for the target's category? |
| fin_working_capital_peg | 4 | FINANCIAL | P1 | OPEN | ANALYST | Normalised working-capital target estimated + reconciled to seller's proposed peg? |
| deliver_qoe | 5 | DELIVERABLE | P0 | OPEN | PARTNER | Quality-of-Earnings memo drafted and reviewed? |
| deliver_ic_packet | 5 | DELIVERABLE | P0 | OPEN | PARTNER | IC Packet assembled (12 sections with partner synthesis + walkaway + open questions)? |
| manual_mgmt_references | 3 | MANUAL | P1 | OPEN | PARTNER | Management team reference calls (CEO / CFO / RCM-ops director) completed? |
| manual_legal_review | 3 | MANUAL | P0 | OPEN | LEGAL | Seller legal review — corporate structure, equity rollover, reps + warranties — signed off? |
| manual_commercial_contract_review | 3 | MANUAL | P0 | OPEN | LEGAL | Commercial payer contract review — top-5 payer contracts' carveouts, escalators, termination clauses, auto-renewal? |
| manual_real_estate_title | 3 | MANUAL | P1 | OPEN | EXTERNAL | Real estate title + environmental + survey report for every owned facility? |
| manual_seller_disclosure | 3 | MANUAL | P1 | OPEN | LEGAL | Seller disclosure schedule review — pending litigation, regulatory audits, DOJ/OIG matters? |
| regulatory_calendar_scan | 3 | RISK | P0 | OPEN | ANALYST | Has the Regulatory Calendar × Thesis Kill-Switch been run to map upcoming CMS / OIG / FTC / DOJ / NSA-IDR events to the target's thesis drivers? |
| covenant_stress_simulation | 4 | FINANCIAL | P0 | OPEN | ANALYST | Has the Covenant & Capital Stack Stress Lab been run to quantify per-quarter covenant-breach probability and equity-cure sizing? |
| hcris_peer_xray | 1 | SCREENING | P0 | OPEN | ANALYST | Has the HCRIS-Native Peer X-Ray benchmarked the target against 25-50 filed Medicare cost reports? |
| payer_mix_stress | 3 | RISK | P1 | OPEN | ANALYST | Has the Payer Mix Stress Lab stress-tested the target's commercial + government payer portfolio? |
Press ? for shortcuts · b to bookmark · ⌘K to jump